title: Crossing borders: surgically mediated drug delivery techniques.
authors.affiliation: Surgical Neurological Branch, National Institutes of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA.
authors.forename: Ashok R
authors.initials: AR
authors.lastname: Asthagiri
authors.forename: Martin
authors.initials: M
authors.lastname: Baggenstos
authors.forename: Russell R
authors.initials: RR
authors.lastname: Lonser
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000493:pharmacokinetics; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D001427:Bacterial Toxins / Q000008:administration & dosage / Q000493:pharmacokinetics; D001682:Biological Availability; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D002330:Carmustine / Q000008:administration & dosage / Q000493:pharmacokinetics; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D004343:Drug Implants; D005098:Exotoxins / Q000008:administration & dosage / Q000493:pharmacokinetics; D005910:Glioma / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D015918:Infusion Pumps, Implantable; D018793:Interleukin-13 / Q000008:administration & dosage / Q000493:pharmacokinetics; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D016499:Radioimmunotherapy; D018714:Radiotherapy, Adjuvant; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000493:pharmacokinetics; D014168:Transferrin / Q000008:administration & dosage / Q000493:pharmacokinetics
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D001427:Bacterial Toxins; D004343:Drug Implants; D005098:Exotoxins; C521502:IL13-PE38; D018793:Interleukin-13; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; C404391:Tf-CRM107; D014168:Transferrin; D002330:Carmustine